Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price: 1,682.60
Bid: 1,679.20
Ask: 1,680.00
Change: 0.00 (0.00%)
Spread: 0.80 (0.05%)
Open: 1,665.00
High: 1,685.40
Low: 1,656.20
Yest. Close: 1,655.20
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

RNS Alerts are a premium feature

Login to your account

myTerminal is a premium feature

Login to your account

Don't have an account? Click here to register.

BROKER RATINGS SUMMARY: Goldman Sachs Says Buy Unilever, Sell M&S

Mon, 2nd Sep 2019 09:41

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and Friday afternoon:



FTSE 100



GOLDMAN SACHS RESUMES MARKS & SPENCER WITH 'SELL' - TARGET 170 PENCE



GOLDMAN RAISES UNILEVER PLC TO 'BUY' (NEUTRAL) - PRICE TARGET 5700 PENCE (4850p)



GOLDMAN CUTS RECKITT BENCKISER PRICE TARGET TO 7100 PENCE (7200p) - 'NEUTRAL'



DEUTSCHE BANK RAISES GLAXOSMITHKLINE PRICE TARGET TO 1645 PENCE (1620p) - 'HOLD'



HSBC CUTS BUNZL PRICE TARGET TO 2450 PENCE (2600p) - 'BUY'



HSBC RAISES FERGUSON PRICE TARGET TO 6600 PENCE (6400p) - 'BUY'



FTSE 250



MORGAN STANLEY CUTS LONDONMETRIC PROPERTY TO 'UNDERWEIGHT' ('EQUAL-WEIGHT') - TARGET 200 PENCE



UBS RAISES BEAZLEY PRICE TARGET TO 650 PENCE (635p) - 'BUY'



GOLDMAN RAISES TATE & LYLE PRICE TARGET TO 800 (770) PENCE - 'NEUTRAL'



HSBC RAISES DIPLOMA PRICE TARGET TO 1575 (1325) PENCE - 'HOLD'



RBC CUTS WH SMITH PRICE TARGET TO 2400 (2500) PENCE - 'OUTPERFORM'



RBC CUTS DERWENT LONDON PRICE TARGET TO 2750 (2800) PENCE - 'UNDERPERFORM'



RBC RAISES DECHRA PHARMACEUTICAL PRICE TARGET TO 2500 PENCE (2100p) - 'SECTOR PERFORM'



OTHER MAIN MARKET AND AIM



BARCLAYS RAISES SMART METERING TO 'OVERWEIGHT' ('EQUAL WEIGHT') - TARGET 545 PENCE (650p)



More News

UPDATE 1-Brexit tussle bogs down UK midcaps

* FTSE 250 down 0.4%, FTSE 100 up 0.2%* Fresnillo at bottom of main index after weak outlook* Exporters benefit from weaker pound (Adds company news items, updates share moves)By Muvija M and Shashwat AwasthiOct 23 (Reuters) - Shares in domestically...

23 Oct 19 09:15

TOP NEWS: GlaxoSmithKline Sells Two Vaccines Amid Growth Assets Focus

TOP NEWS: GlaxoSmithKline Sells Two Vaccines Amid Growth Assets Focus

21 Oct 19 08:16

GlaxoSmithKline offloads two travel vaccines to Bavarian Nordic

(Sharecast News) - GlaxoSmithKline announced the divestment of travel vaccines 'Rabipur', known as Rabavert in the US and used for the prevention of rabies, and 'Encepur' for the prevention of tick-borne encephalitis, to Bavarian Nordic on Monday.

21 Oct 19 08:10

Teva's UK arm recalls some batches of Ranitidine - Medicines watchdog

Oct 17 (Reuters) - Teva Pharmaceutical's UK unit has recalled some batches of heartburn medicine Ranitidine, Britain's medicines watchdog said on Thursday, making it the latest drugmaker to pull the product.Teva, the world's largest generic drugma...

17 Oct 19 15:50

CORRECT: UK BROKER RATINGS SUMMARY: Shore Keeps Asos At Sell

CORRECT: UK BROKER RATINGS SUMMARY: Shore Keeps Asos At Sell

14 Oct 19 11:06

UK BROKER RATINGS SUMMARY: Shore Cuts Asos To Sell From Hold

UK BROKER RATINGS SUMMARY: Shore Cuts Asos To Sell From Hold

14 Oct 19 09:23

UPDATE 1-FTSE falters as Brexit hopes lift pound; domestic stocks rejoice

* FTSE 100 down 0.3%, FTSE 250 up 0.8%* Brexit deal hopes lift sterling, hit exporters* Housebuilders, UK banks jump* WPP, Burberry fall after European rivals cut forecast* Dart Group climbs higher after hiking profit view (Adds news items, analyst ...

11 Oct 19 09:07

UPDATE 1-British blue-chips trail Europe as Brexit deal hopes lift pound

* FTSE 100 up 0.1%, FTSE 250 down 0.1%* GVC gains after forecast upgrade* Just Eat tops blue-chip risersBy Muvija M and Shashwat AwasthiOct 9 (Reuters) - London's exporter-laden FTSE 100 lagged its European peers on Wednesday, as sterling gained on ...

9 Oct 19 10:21

UPDATE 1-GSK recalls popular heartburn medicine Zantac - U.K. medicines watchdog

(Adds context on U.S. FDA move)Oct 8 (Reuters) - GlaxoSmithKline Plc is recalling its heartburn medicine Zantac as a "precautionary measure" due to a probable cancer-causing impurity in the drug, Britain's medicines watchdog said on Tuesday.The mo...

8 Oct 19 16:53

UPDATE 2-GSK recalls prescription-only versions of heartburn drug Zantac

* Four products recalled; over-the-counter ones not affected* UK regulator says recall a "precautionary measure"* Regulators investigating ranitidine drugs for impurities (Adds details on products affected, context on other drugmakers halting suppl...

8 Oct 19 16:53

UPDATE 3-GSK recalls popular heartburn drug Zantac globally after cancer scare

* GSK recalls Zantac products in all markets as a "precaution"* Four products recalled; OTC ones not affected -UK regulator* GSK says working with regulators to address concerns (Tweaks headline, first paragraph; adds company comment)By Justin Geo...

8 Oct 19 16:53

Drug Alert As GlazoSmithKline Recalls Zantac; Collaboration Launched

Drug Alert As GlazoSmithKline Recalls Zantac; Collaboration Launched

8 Oct 19 16:33

GSK recalls popular heartburn medicine Zantac - U.K. medicines watchdog

Oct 8 (Reuters) - GlaxoSmithKline Plc is recalling its heartburn medicine Zantac as a "precautionary measure" due to a probable cancer-causing impurity in the drug, Britain's medicines watchdog said on Tuesday.GSK is recalling all unexpired stock ...

8 Oct 19 16:25

UPDATE 2-Trade hopes lift FTSE 100, SIG drags down mid-caps

* FTSE 100 up 0.6%, FTSE 250 dips 0.3%* Hopes for U.S.-China deal help blue-chips* Mid-cap SIG plummets after profit warning (Adds company news items, updates share moves)By Muvija M and Shashwat AwasthiOct 7 (Reuters) - Oil majors led a rebound in ...

7 Oct 19 09:29

UPDATE 1-Vectura, Sandoz win ruling on inhaler packaging case against GSK

(Adds comment from GSK spokesman)Oct 4 (Reuters) - Vectura Group said on Friday a British court had ruled in its favour on the packaging of a generic version of an inhaler made by bigger rival GlaxoSmithKline.Vectura said the court dismissed all G...

4 Oct 19 17:31

Login to your account

Don't have an account? Click here to register.